Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 119 of the 119 references it cites were found in a registry or an index.

Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis

Open access

Abstract

BACKGROUND: Statins have uncertain benefits in persons with chronic kidney disease (CKD) because individual trials may have insufficient power to determine whether treatment effects differ with severity of CKD. PURPOSE: To summarize the benefits and harms of statin therapy for adults with CKD and examine whether effects of statins vary by stage of kidney disease. DATA SOURCES: Cochrane and EMBASE databases (inception to February 2012). STUDY SELECTION: Randomized trials comparing the effects of statins with placebo, no treatment, or another statin on mortality and cardiovascular outcomes. DATA EXTRACTION: Two independent reviewers extracted data and assessed risk of bias. DATA SYNTHESIS: Eighty trials comprising 51099 participants compared statin with placebo or no treatment. Treatment effects varied with stage of CKD. Moderate- to high-quality evidence indicated that statins reduced all-cause mortality (relative risk [RR], 0.81 [95% CI, 0.74 to 0.88]), cardiovascular mortality (RR, 0.78 [CI, 0.68 to 0.89]), and cardiovascular events (RR, 0.76 [CI, 0.73 to 0.80]) in persons not receiving dialysis. Moderate- to high-quality evidence indicated that statins had little or no effect on all-cause mortality (RR, 0.96 [CI, 0.88 to 1.04]), cardiovascular mortality (RR, 0.94 [CI, 0.82 to 1.07]), or cardiovascular events (RR, 0.95 [CI, 0.87 to 1.03]) in persons receiving dialysis. Effects of statins in kidney transplant recipients were uncertain. Statins had little or no effect on cancer, myalgia, liver function, or withdrawal from treatment, although adverse events were evaluated systematically in fewer than half of the trials. LIMITATION: There was a reliance on post hoc subgroup data for earlier stages of CKD. CONCLUSION: Statins decrease mortality and cardiovascular events in persons with early stages of CKD, have little or no effect in persons receiving dialysis, and have uncertain effects in kidney transplant recipients.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-157-4-201208210-00007

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 119 references

Research works printed but not linked: 19

  1. Navaneethan SD, 2009, Cochrane Database Syst Rev, CD004289
  2. Navaneethan SD, 2009, Cochrane Database Syst Rev, CD007784
  3. Navaneethan SD, 2009, Cochrane Database Syst Rev, CD005019
  4. National Kidney Foundation, 2002, Am J Kidney Dis, 39, S1
  5. Mori Y, 1992, Journal of the Japan Diabetes Society, 35, 265
  6. Martinez Hernandez BE, 1993, Nephrol Dial Transplant, 8, 637
  7. Aranda Arcas JL, 1994, An Med Interna, 11, 523
  8. Rayner BL, 1996, Clin Nephrol, 46, 219
  9. Paczek L, 1997, Pol Arch Med Wewn, 97, 144
  10. Dummer CD, 2008, J Nephrol, 21, 900
  11. Tse KC, 2008, J Nephrol, 21, 283
  12. Burmeister JE, 2009, J Nephrol, 22, 83
  13. Renke M, 2010, Acta Biochim Pol, 57, 547
  14. Gupta AK, 2011, J Hum Hypertens, 25, 633
  15. 10.1016/s0140-6736(11)60739-3 · DOI · Paper page
  16. Castelao AM, 1993, Transplant Proc, 25, 1043
  17. Raiola P, 1998, J Am Soc Nephrol, 9, 693A
  18. Vergoulas G, 1999, Nephrol Dial Transplant, 14, A312
  19. van den Akker JM, 2003, J Nephrol, 16, 238

Cited by

See all 370

Metadata

Authors
Palmer, S. C., Craig, J. C., Navaneethan, S. D., Tonelli, M., Pellegrini, F., & Strippoli, G. F. M.
Affiliations
The University of Sydney (AU)
Venue
Annals of Internal Medicine
Published
2012-08-21
Volume
157
Issue
4
Pages
263-275
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1967917591
Cited by
359
References
119
Citations by year
2026: 10 · 2025: 23 · 2024: 8 · 2023: 16 · 2022: 16 · 2021: 21 · 2020: 16 · 2019: 27 · 2018: 17 · 2017: 20 · 2016: 21 · 2015: 50 · 2014: 56 · 2013: 53 · 2012: 4
FWCI
10.09
Type
journal article
Language
en
Open access
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5kl2rr024990-05)
  • National Center for Research Resources (KL2-RR-024990)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
statins, chronic kidney disease, dialysis, kidney transplant recipients, all-cause mortality, cardiovascular mortality, cardiovascular events, statin adverse effects, cancer risk, myalgia, liver function, treatment withdrawal, CKD stage
MeSH terms
Cardiovascular Diseases, Cause of Death, Renal Dialysis, Humans, Lipids, Sensitivity and Specificity, Bias, Kidney Transplantation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis. https://app.cochat.ai/papers/10.7326/0003-4819-157-4-201208210-00007
The paper
Palmer, S. C., Craig, J. C., Navaneethan, S. D., Tonelli, M., Pellegrini, F., & Strippoli, G. F. M. (2012). Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-157-4-201208210-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.